A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

Results From Prospective, Multi-Center, Pivotal Clinical Trial on the EyeArt® AI Eye Screening System to be Announced by Eyenuk Inc. at the ARVO Conference

Eyenuk Inc., a global artificial intelligence (AI) medical technology and services company and the leader in real-world applications for AI Eye Screening™, announced today that it will release results from its prospective, multi-center, pivotal clinical trial (NCT03112005) on the EyeArt® AI Eye Screening System for autonomous detection of diabetic retinopathy (DR) at the Association for Research in Vision and Ophthalmology (ARVO) Imaging in the Eye Conference this weekend in Vancouver, British Columbia.

  • On behalf of the 15-center study team, Jennifer Lim, MD, Marion H. Schenk Chair in Ophthalmology and Director of Retina Service at the University of Illinois at Chicago, will present results from the EyeArt prospective, pivotal clinical trial “Artificial Intelligence Screening for Diabetic Retinopathy: Analysis From a Pivotal Multi-Center Prospective Clinical Trial.” The presentation will be part of the 2019 ARVO Imaging in the Eye Conference at 5:15 p.m. PDT on Saturday, April 27, 2019, in the Vancouver Convention Centre (East) Ballroom A and B.
  • In addition, the clinical team from the Washington University School of Medicine (St. Louis) will present results from its independent clinical study involving the EyeArt® AI Eye Screening System in real-world clinical applications:
    • “Cost-Effectiveness of Primary Care-Based Non-Mydriatic Fundus Photography with Automated Retinal Image Analysis Screening Among Low-Income Patients with Diabetes,” which will be presented at 11 a.m. PDT on Wednesday, May 1, 2019, in the Vancouver Convention Centre (West) Room 220.
    • “Diabetic Retinopathy Screening in a Primary Care Setting Using Non-Mydriatic Photography and Automated Retinal Image Analysis Improves Compliance with Follow-Up Ophthalmic Care,” which will be Poster B0005 at 3 p.m. PDT on Wednesday, May 1, 2019, in the Vancouver Convention Centre West Exhibition Hall.

Eyenuk Inc. will showcase its EyeArt® AI Eye Screening System for autonomous detection of DR at Booth #1637 at the Vancouver Convention Centre Exhibition Hall. In addition, key management team members will be available to meet with researchers, clinicians and potential industry partners during the ARVO annual meeting..

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy